MTHFD2 and familial pancreatic carcinoma: MTHFD2, which comprises this pathway and has two enzymatic activities, dehydrogenase and cyclohydrolase, is reported to be highly expressed at the protein level in a variety of human tumors, including pancreatic cancer, and is negatively correlated with survival [23, 24].